Pyxis Oncology's Lara Sullivan, M.D. On Site-Specific ADCs And Change Management

We love to hear from our listeners. Send us a message. To fully appreciate the work Pyxis Oncology is doing in its development of site-specific ADCs for a number of oncological indications under the leadership of Lara Sullivan, M.D., you need to understand the work that shaped her leadership style. On this episode of the Business of Biotech, Dr. Sullivan shares the science and technology driving progress at Pyxis, but she also serves up a master class on change management, honed during her te...